Comprehensive End-to-End Services to Ensure Bioequivalence Success​

Resolving stability-related challenges throughout the product lifecycle​

Addressing dissolution issues, including F2 failure cases​

Supporting responses to regulatory queries with scientific and strategic input​

Designing polymorphism studies tailored to specific product requirements​

Conducting reverse engineering of Reference Listed Drugs (RLDs)​

Facilitating connections with the right formulation development partners​

Planning and executing sameness studies to meet regulatory expectations​

Dossier compilation, review, and regulatory compliance support​

Assisting in the development of GLP-1 and other complex molecules​

Leveraging PBPK modeling and AI-based in silico tools to support decision-making during bioequivalence studies, and in many cases, to justify waivers for in vivo studies​

Isolation and Qualification of Impurities.​

Nitrosamines control & compliance.​